More attention is being focused on malaria today than any time since the world's last efforts
to achieve eradication over 40 years ago. The global community is now discussing …

Population studies show that individuals acquire immunity to Plasmodium vivax more
quickly than Plasmodium falciparum irrespective of overall transmission intensity, resulting …

Multiplicity of infection (MOI), also termed complexity of infection (COI), is defined as the
number of genetically distinct parasite strains co-infecting a single host, which is an …

In a recent vaccine trial performed with African children, immunization with a recombinant
protein based on Plasmodium falciparum apical membrane antigen 1 (AMA-1) conferred a …

Plasmodium vivax is part of a highly diverse clade that includes several Plasmodium
species found in nonhuman primates from Southeast Asia. The diversity of primate malarias …

Background Understanding the population structure of Plasmodium species through genetic
diversity studies can assist in the design of more effective malaria control strategies …

Plasmodium vivax apical membrane antigen-1 (PvAMA-1) is a major candidate antigen for
human malaria vaccine. In the present study, polymorphism of pvama-1 among Iranian …

Malaria is endemic or hypoendemic in Myanmar and the country still contributes to the high
level of malaria deaths in South-East Asia. Although information on the nature and extent of …

Plasmodium vivax, a major contributor to the malaria burden in India, has the broadest
geographic distribution and shows higher genetic diversity than P. falciparum. Here, we …

Background Identifying highly immunogenic blood stage antigens which can work as target
for naturally acquired antibodies in different eco-epidemiological settings is an important …